Profile data is unavailable for this security.
About the company
Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.
- Revenue in USD (TTM)2.90m
- Net income in USD-6.48m
- Incorporated2022
- Employees45.00
- LocationMoolec Science SA17, Boulevard F.W. RaiffeisanLUXEMBOURG 2411LuxembourgLUX
- Websitehttp://www.moolecscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp | 404.72k | -5.44m | 44.26m | 5.00 | -- | 5.87 | -- | 109.36 | -0.6851 | -0.6851 | 0.0493 | 0.5264 | 0.0722 | -- | 1.64 | 80,944.00 | -97.62 | -95.67 | -94.18 | -96.58 | 95.66 | 76.98 | -1,351.64 | -1,612.76 | -- | -175.33 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
| NextCure Inc | 0.00 | -63.73m | 44.76m | 82.00 | -- | 0.4508 | -- | -- | -2.29 | -2.29 | 0.00 | 3.55 | 0.00 | -- | -- | 0.00 | -45.05 | -22.59 | -47.72 | -23.54 | -- | -- | -- | -964.96 | -- | -- | 0.00 | -- | -- | -- | 16.07 | -- | -23.17 | -- |
| Immuneering Corp | 0.00 | -54.18m | 44.78m | 65.00 | -- | 0.5688 | -- | -- | -1.86 | -1.86 | 0.00 | 2.65 | 0.00 | -- | -- | 0.00 | -55.37 | -- | -58.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -5.86 | -- | -- | -- |
| Dare Bioscience Inc | 2.82m | -28.87m | 45.47m | 23.00 | -- | -- | -- | 16.14 | -0.3175 | -0.3175 | 0.0308 | -0.1094 | 0.1299 | -- | 1.49 | 122,486.50 | -133.12 | -109.51 | -4,386.38 | -246.26 | 0.0579 | -- | -1,024.93 | -1,104.55 | -- | -- | -- | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| Inotiv Inc | 552.74m | -71.29m | 45.71m | 1.96k | -- | 0.2201 | -- | 0.0827 | -2.77 | -2.77 | 21.44 | 8.00 | 0.6565 | 7.18 | 7.91 | 282,733.50 | -8.58 | -23.84 | -13.63 | -29.26 | 28.76 | 29.31 | -13.07 | -33.24 | 0.2744 | -0.1734 | 0.6476 | -- | 4.52 | 85.10 | 68.80 | -- | 83.64 | -- |
| Moolec Science SA | 2.90m | -6.48m | 47.09m | 45.00 | -- | 6.18 | -- | 16.25 | -0.2079 | -0.2079 | 0.0838 | 0.1779 | 0.1302 | -- | 4.81 | 64,382.45 | -29.13 | -- | -51.98 | -- | 10.67 | -- | -223.70 | -- | 0.3681 | -9.90 | 0.555 | -- | -- | -- | -1,044.02 | -- | -- | -- |
| Carisma Therapeutics Inc | 15.07m | -81.22m | 47.36m | 107.00 | -- | 4.35 | -- | 3.14 | -2.01 | -2.01 | 0.3723 | 0.2623 | 0.1311 | -- | -- | 140,869.20 | -70.64 | -30.87 | -83.17 | -34.47 | -- | -- | -538.81 | -255.66 | -- | -- | 0.1717 | -- | -62.70 | -- | -336.93 | -- | 255.27 | -- |
| Curis Inc | 9.81m | -47.73m | 47.92m | 48.00 | -- | 5.06 | -- | 4.88 | -8.68 | -8.68 | 1.77 | 1.61 | 0.1253 | -- | 4.39 | 204,416.70 | -60.97 | -37.25 | -69.58 | -41.12 | 97.60 | 96.05 | -486.45 | -409.44 | -- | -- | 0.00 | -- | -1.37 | -0.7891 | 16.34 | -- | -- | -- |
| Arca Biopharma Inc | 0.00 | -6.00m | 48.02m | 4.00 | -- | 1.37 | -- | -- | -0.4155 | -0.4155 | 0.00 | 2.42 | 0.00 | -- | -- | 0.00 | -15.24 | -27.78 | -15.81 | -29.38 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 46.21 | -- | -- | -- |
| IN8BIO, Inc. | 0.00 | -31.04m | 48.10m | 31.00 | -- | 2.69 | -- | -- | -0.9154 | -0.9154 | 0.00 | 0.4049 | 0.00 | -- | -- | 0.00 | -123.61 | -74.18 | -145.63 | -84.42 | -- | -- | -- | -- | -- | -- | 0.0556 | -- | -- | -- | -5.21 | -- | -4.54 | -- |
| Ocean Biomedical Holdings Inc | 0.00 | -45.58m | 48.86m | 9.00 | -- | -- | -- | -- | -1.40 | -1.40 | 0.00 | -0.0642 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -612.50 | -- | -- | -- |
| Clene Inc. | 620.00k | -48.81m | 49.20m | 82.00 | -- | 11.54 | -- | 79.36 | -0.4764 | -0.4764 | 0.0053 | 0.0332 | 0.0146 | 2.11 | 9.76 | 7,560.98 | -114.91 | -39.43 | -233.02 | -47.32 | 78.71 | -- | -7,873.23 | -5,261.20 | 1.22 | -32.64 | 0.8641 | -- | 38.27 | -- | -65.47 | -- | -- | -- |
| Bright Green Corp | 0.00 | -11.46m | 49.65m | 5.00 | -- | 4.47 | -- | -- | -0.0631 | -0.0631 | 0.00 | 0.0584 | 0.00 | -- | -- | 0.00 | -56.05 | -- | -84.87 | -- | -- | -- | -- | -- | -- | -18,125.84 | 0.0289 | -- | -- | -- | 52.54 | -- | -- | -- |
| Kezar Life Sciences Inc | 7.00m | -101.87m | 49.69m | 58.00 | -- | 0.2648 | -- | 7.10 | -1.40 | -1.40 | 0.0965 | 2.58 | 0.0269 | -- | -- | 120,689.70 | -39.12 | -32.54 | -41.41 | -34.09 | -- | -- | -1,455.29 | -4,308.11 | -- | -- | 0.051 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
Data as of Jun 14 2024. Currency figures normalised to Moolec Science SA's reporting currency: US Dollar USD
0.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baker Avenue Asset Management LPas of 31 Mar 2024 | 62.50k | 0.17% |
| Geode Capital Management LLCas of 31 Mar 2024 | 13.65k | 0.04% |
| Johnson Investment Counsel, Inc.as of 31 Mar 2024 | 12.50k | 0.03% |
| UBS Securities LLCas of 31 Mar 2024 | 7.05k | 0.02% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 829.00 | 0.00% |
| BofA Securities, Inc.as of 31 Mar 2024 | 50.00 | 0.00% |
| Exos Asset Management LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| Elequin Securities LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| Lumyna Investments Ltd.as of 30 Sep 2022 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
